"Tazni": A phase I/II combination trial of tazemetostat with nivolumab and ipilimumab for children with INI1-negative or SMARCA4-deficient tumors (NCT05407441) Meeting Abstract
| Authors: | Yi, J. S.; Czaplinski, J.; Bhushan, K.; Forrest, S. J.; Shukla, N.; Mack, S.; Hong, A.; Strachan, M.; Dubois, S. G.; London, W. B.; Chi, S. N. |
| Abstract Title: | "Tazni": A phase I/II combination trial of tazemetostat with nivolumab and ipilimumab for children with INI1-negative or SMARCA4-deficient tumors (NCT05407441) |
| Meeting Title: | 21st International Symposium on Pediatric Neuro-Oncology (ISPNO 2024) |
| Journal Title: | Neuro-Oncology |
| Volume: | 26 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2024 Jun 28-July 2 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001252720000756 |
| DOI: | 10.1093/neuonc/noae064.168 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TRLS-15 -- Source: Wos |
